As telehealth advocates return to Capitol Hill to press for an extension of COVID-19 pandemic flexibilities that have allowed for the prescription of controlled substances, some new ideas are surfacing as advocates seek lawmakers’ support: Congress could set an age limit on who can access controlled substance via telehealth or could specify only certain drugs be part of a legislative removal of the Ryan Haight in-person requirement for Schedule 3, 4 and 5 drugs. Telehealth lobbyists were unable to get...